Lavipharm selects DIS for its digital transformation
Lavipharm has partnered with DIS to implement a comprehensive Microsoft Dynamics 365 Finance & Supply Chain Management project as part of its digital transformation efforts.
Stock Market - Lavipharm: The Rally Grows, the P/E Becomes Expensive
Lavipharm's stock continues its upward trend, approaching a 35% increase since the beginning of the year, while its valuation exceeds 220 million euros and the P/E ratio rises to 73x.